| Literature DB >> 35799699 |
Paul van Amstel1,2,3,4, Sarah-May M L The1,2,3,5, Irene M Mulder6, Roel Bakx1,2,3, Joep P M Derikx1,2,3,4, Joost van Schuppen7,8, Ralph de Vries9, Martijn van der Kuip10,11, Gerda W Zijp6, Jan Hein Allema6, Taco S Bijlsma5, L W Ernest van Heurn1,2,3,4, Ramon R Gorter1,2,3,4.
Abstract
Introduction: Recent studies have shown that specific cases of post-appendectomy abscess (PAA) in children could be treated conservatively. However, due to the lack of high-quality evidence, choice of treatment still depends on preferences of the treating surgeon, leading to heterogeneity in clinical practice. Therefore, we aimed to provide an update of recent literature on the management of PAA in children and subsequently evaluate the outcomes of a large multicenter cohort of children treated for PAA.Entities:
Keywords: appendicitis; children; invasive treatment; non-invasive treatment; post-appendectomy abscess
Year: 2022 PMID: 35799699 PMCID: PMC9254404 DOI: 10.3389/fped.2022.908485
Source DB: PubMed Journal: Front Pediatr ISSN: 2296-2360 Impact factor: 3.569
FIGURE 1Preferred reporting items for systematic reviews and meta-analysis (PRISMA) flowchart.
Results of the systematic review.
| Author (year) | Study design | Intervention | Treatment success | Additional intervention | Complication |
| Svetanoff et al. ( | Prospective cohort | AB: 8 | 7 (88%) | 1 surgery | Small bowel obstruction: 1 |
| PD: 22 | 21 (95%) | 1 PD/SD | Recurrent abscess: 1 | ||
| Gorter et al. ( | Historical cohort | AB: 13 | 9 (69%) | 4 PD, 1 SD | Persistent/recurrent abscess: 4 |
| PD: 9 | 5 (56%) | 2 PD, 4 SD | Persistent/recurrent abscess: 3 | ||
| Iatrogenic bowel perforation: 1 | |||||
| Secondary bowel obstruction: 2 | |||||
| Splenic hemorrhage: 1 | |||||
| Superficial site infection: 1 | |||||
| SBO due to adhesions: 1 | |||||
| SD: 3 | 3 (100%) | – | – | ||
| Emil et al. ( | Historical cohort | AB: 21 | 18 (86%) | 2 PD, 1 SD | Persistent/recurrent abscess: 3 |
| PD: 19 | 18 (95%) | 1 SD | Persistent/recurrent abscess: 1 | ||
| SD: 2 | 2 (100%) | – | – |
AB, antibiotics; PD, percutaneous drainage; SD, surgical drainage.
Baseline characteristics.
| Non-invasive | Invasive | ||
| Male gender | 16 (44.8%) | 24 (58.5%) | 0.258 |
| Age (years)^ | 9.3 ± 3.8 | 10.2 ± 4.0 | 0.338 |
| Appendicitis severity | 1.0 | ||
| - Simple | 4 (14%) | 6 (15%) | |
| - Complex | 25 (86%) | 33 (80%) | |
| - |
|
| |
| Surgical approach | 0.045 | ||
| - Laparoscopic | 17 (59%) | 33 (80%) | |
| - Open | 11 (38%) | 7 (17%) | |
| - |
|
| |
| Time after appendectomy (days) | 9 (6.5–13) | 9 (6–12.5) | 0.957 |
| Temperature at diagnosis PAA | 37.6 (37.1–38.3) | 37.7 (37.1–38.6) | 0.496 |
| Leukocytes at diagnosis PAA (x109/L) | 17.3 (14.0–24.3) | 18.0 (15.0–22.2) | 0.760 |
| CRP at diagnosis PAA (g/dL) | 105 (74–191) | 154 (83–216) | 0.458 |
| PAA size | <0.001 | ||
| - Small (< 3 cm) | 7 (24%) | 1 (2%) | |
| - Medium (3–6 cm) | 15 (52%) | 12 (29%) | |
| - Large (>6 cm) | 3 (10%) | 16 (39%) | |
| - Multiple | 3 (10%) | 11 (27%) | |
| - |
|
| |
| PAA location | 0.155 | ||
| - RLQ | 14 (48%) | 15 (37%) | |
| - RUQ | 4 (14%) | 2 (5%) | |
| - Douglas space | 6 (21%) | 13 (32%) | |
| - LLQ | 1 (3%) | – | |
| - LUQ | 1 (3%) | – | |
| - Multiple | 3 (10%) | 11 (27%) |
* Median (IQR).
Treatment success rate, secondary interventions, and complications.
| Non-invasive | Invasive | |
|
| ||
| - Small (<3 cm) | 7/7 (100%) | 1/1 (100%) |
| - Medium (3–6 cm) | 12/15 (80%) | 8/12 (67%) |
| - Large (>6 cm) | 2/3 (67%) | 10/16 (63%) |
| - Multiple | 0/3 (0%) | 7/11 (64%) |
| - Unknown size | 0/1 (0%) | 1/1 (100%) |
| Persistent/recurrent abscess | 7 (24%) | 9 (22%) |
|
| ||
| - Percutaneous drainage | 5 | 5 |
| - Open drainage | 1 | 2 |
| - Laparoscopic drainage | 1 | – |
| - Oral antibiotics (outpatient clinic) | – | 1 |
| - IV antibiotics + admission | – | 1 |
| - Intervention for other complication | 1 | 5 |
|
| ||
| - Ileus | – | 3 (2x CD-III, 1x CD-II |
| - Surgical Site Infection | – | 1 (CD-III) |
| - Incisional hernia | – | 1 (CD-III) |
| - CVC related infection | – | 1 (CD-II) |
| - Pleural empyema | 1 (CD-III) | – |
| - Fistula | 1 (CD-II) | – |
| - Suspicion of bowel perforation | – | 1 (CD-III) |
| - Fever | – | 1 (CD-II) |
| - Vaginal blood loss after transrectal drainage procedure | – | 1 (CD-I) |
Data is displayed as count (percentage).
CD, clavien-dindo; CVC, central venous catheter; IV, intravenous.
Primary outcome divided by participating center.
| Non-invasive ( | Invasive ( | |
|
| ||
| - Small (<3 cm) | 2/2 (100%) | – |
| - Medium (3–6 cm) | 3/4 (75%) | 2/4 (50%) |
| - Large (>6 cm) | 1/1 (100%) | 5/9 (56%) |
| - Multiple | – | 3/6 (50%) |
|
| ||
|
|
| |
|
| ||
|
| ||
| - Small (<3 cm) | 4/4 (100%) | – |
| - Medium (3–6 cm) | 9/10 (90%) | 0/1 (0%) |
| - Large (>6 cm) | 1/2 (50%) | 0/1 (0%) |
| - Multiple | 0/3 (0%) | 1/1 (100%) |
| - Unknown size | – | 1/1 (100%) |
|
| ||
|
|
| |
|
| ||
|
| ||
| - Small (<3 cm) | 1/1 (100%) | 1/1 (100%) |
| - Medium (3–6 cm) | 0/1 (0%) | 6/7 (86%) |
| - Large (>6 cm) | – | 5/6 (83%) |
| - Multiple | – | 3/4 (75%) |
| - Unknown size | 0/1 (0%) | – |
Data is displayed as count (percentage of total).
Secondary outcomes.
| Non-invasive ( | Invasive ( | |
| Initial length of stay (day) | 7 (0–17) | 8 (4–31) |
| Total length of stay (day) | 7 (0–17) | 9 (4–31) |
| No. of imaging studies per patient | 3 (2–4) | 4 (3–6) |
| No. of ultrasounds per patient | 3 (0–5) | 4 (0–14) |
| No. of MRIs per patient | 0 (0–3) | 0 (0–3) |
| No. of CT-scans per patient | 0 (0–1) | 0 (0–2) |
| No. of readmitted patients* | 1 | 7 |
| Number of readmissions* | 1 | 9 |
| Outpatient visits | 2 (0–7) | 1 (0–9) |
| Telephone check-up | 0 (0–4) | 0 (0–4) |
Data is displayed as median (range). *Data is displayed as count.
FIGURE 2Standardized treatment protocol.